TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
The Pharma Data
JULY 11, 2021
Hereditary angioedema is a lifelong condition and research shows that concerns about another attack can limit the way patients lead their lives,” said Prof. Department of Dermatology, Venereology and Allergology, Charité – Universitätsmedizin in Berlin, Germany. percent (-100; 852.8), and the median reduction was 97.7
52 
Let's personalize your content